Bjørn Henning Grønberg

Professor Institutt for klinisk og molekylær medisin

bjorn.h.gronberg@ntnu.no 72826170 47297878

Kunnskapssenteret, Øya, St. Olavs Hospital

bjorn.h.gronberg@ntnu.no

Lege og kreftspesialist. Bistilling som overlege ved Kreftklinikken, St. Olavs Hospital, med ansvar for behandling av lungekreft. Hovedstilling som forsker ved Institutt for Kreftforskning og molekylær medisin, NTNU. Instituttgruppeleder for Instituttgruppe for kreft og pasientnær forskning. Driver mest med klinisk lungekreftforskning, men forsker også på helserelatert livskvalitet, kreft hos eldre, kroppssammensetning, pasientinformasjon, og pasientforløp. Har etablert translasjonsforskningsgruppe som forsker liquid biopsies hos kreftpasienter.

Utdanning:

Cand. med., Universitetet i Bergen, 1994
Spesialist i behandling av kreftsykdommer, St. Olavs Hospital, 2001
Doktorgrad (PhD i klinisk medisin), NTNU, 2010

Forskningsinteresser:

Lungekreft
Eldre og kreft
ctDNA

Pågående studier:

Nordic randomized phase II study comparing two schedules of hyperfractionated thoracic radiotherapy in limited disease small-cell lung cancer
Randomized phase III study comparing maintenance pemetrexed therapy after induction chemotherapy versus pemetrexed at progression in advanced non-small-cell lung cancer
The prognostic and predictive role of ctDNA-analyses in lung cancer patients who undergo surgery

Vitenskapelig, faglig og kunstnerisk arbeid

Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen

Tidsskriftspublikasjoner

Kirkhus, Lene; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Grønberg, Bjørn Henning; Hjermstad, Marianne Jensen; Selbæk, Geir; Wyller, Torgeir Bruun; Harneshaug, Magnus; Jordhøy, Marit Slaaen. (2017) Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty. British Journal of Cancer.
Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Amundsen, Tore; Hjelde, Harald Harris; Kaasa, Stein; Sørhaug, Sveinung; Grønberg, Bjørn Henning. (2017) Measurement of health-related quality of life during chemotherapy -the importance of timing. Acta Oncologica. vol. 56 (5).
Kristensen, Are Korsnes; Solheim, Tora Skeidsvoll; Grønberg, Bjørn Henning. (2017) Livskvalitet under cellegiftbehandling -betydning av måletidspunkt. Best Practice Onkologi/Hematologi.
Pettersen, Kristine; Andersen, Sonja Benedikte; Degen, simone; Tadini, Valentina; Grosjean, Joel; Hatakeyama, Shinji; Tesfahun, Almaz Nigatu; Moestue, Siver Andreas; Kim, Jana; Nonstad, Unni; Romundstad, Pål Richard; Skorpen, Frank; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning; Strasser, Florian; Stephens, Nathan; Hoem, Dag; Molven, Anders; Kaasa, Stein; Fearon, Kenneth; Jacobi, Carsten; Bjørkøy, Geir. (2017) Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Scientific Reports. vol. 7 (1).
Sjøblom, Bjørg; Saltyte Benth, Jurate; Grønberg, Bjørn Henning; Baracos, Vickie E.; Sawyer, Michael; Fløtten, Øystein; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Jordhøy, Marit Slaaen. (2017) Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer. vol. 18 (2).
Stokstad, Trine; Sørhaug, Sveinung; Amundsen, Tore; Grønberg, Bjørn Henning. (2017) Medical complexity and time to lung cancer treatment - A three-year retrospective chart review. BMC Health Services Research. vol. 17:45.
Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd; Al-Saad, Samer; Brustugun, Odd Terje; Helland, Åslaug; Lund-Iversen, Marius; Solberg, Steinar; Grønberg, Bjørn Henning; Wahl, Sissel Gyrid Freim; Helgeland, Lars; Fløtten, Øystein; Pohl, M; Al-Shibli, Khalid; Sandanger, Torkjel M; Pezzella, Francesco; Busund, Lill-Tove; Bremnes, Roy M.. (2016) Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology. vol. 27 (2).
Fløtten, Øystein; Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Helbekkmo, Nina; Bremnes, Roy M.; Plessen, Christian von. (2016) Oral versus intravenous vinorelbine in advanced NSCLC - a retrospective comparison. Cancer treatment and research communication. vol. 9.
Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Tollåli, Terje; Hornslien, Kjersti; Aksnessæther, Bjørg Y.; Liaaen, Erik Dyb; Sundstrøm, Stein Harald. (2016) Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer. Acta Oncologica. vol. 55 (5).
Halvorsen, Tarje Onsøien; Herje, Martin; Levin, Nina; Bremnes, Roy M.; Brustugun, Odd Terje; Fløtten, Øystein; Kaasa, Stein; Sundstrøm, Stein Harald; Grønberg, Bjørn Henning. (2016) Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer. Lung Cancer. vol. 102.
Halvorsen, Tarje Onsøien; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf; Bremnes, Roy M.; Kaasa, Stein; Grønberg, Bjørn Henning. (2016) Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncologica. vol. 55 (11).
Kirkhus, Lene; Jordhøy, Marit; Saltyte Benth, Jurate; Kristjansson, Siri Rostoft; Selbæk, Geir; Hjermstad, Marianne Jensen; Grønberg, Bjørn Henning. (2016) Comparing comorbidity scales: Attending physician score versus the Cumulative Illness Rating Scale for Geriatrics. Journal of Geriatric Oncology. vol. 7 (2).
Kristensen, Are Korsnes; Vagnildhaug, Ola Magne; Grønberg, Bjørn Henning; Kaasa, Stein; Laird, Barry J; Solheim, Tora Skeidsvoll. (2016) Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. Critical reviews in oncology/hematology. vol. 99.
Sjøblom, Bjørg; Grønberg, Bjørn Henning; Wentzel-Larsen, Tore; Baracos, Vickie E.; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Bremnes, Roy M.; Fløtten, Øystein; Bye, Asta; Jordhøy, Marit Slaaen. (2016) Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer. Clinical Nutrition. vol. 35 (6).
Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica. vol. 54 (3).
Grønberg, Bjørn Henning; Levin, Nina; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.; Kaasa, Stein; Halvorsen, Tarje Onsøien. (2015) Reduction in tumor size after the first course of cisplatin/etoposide (PE) in limited disease small-cell lung cancer (LD SCLC). Journal of Clinical Oncology. vol. 33.
Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Bremnes, Roy M.; Kaasa, Stein; Halvorsen, Tarje Onsøien. (2015) Associations between Comorbidity, Treatment Toxicity and Overall Survival in Limited Disease Small-Cell Lung Cancer (LD-SCLC). Journal of Thoracic Oncology. vol. 10 (9).
Simmons, Claribel P; Koinis, Filippos; Fallon, Marie T.; Fearon, Kenneth C.; Bowden, Jo; Solheim, Tora Skeidsvoll; Grønberg, Bjørn Henning; McMillan, Donald C; Gioulbasanis, Ioannis; Laird, Barry J. (2015) Prognosis in advanced lung cancer - A prospective study examining key clinicopathological factors. Lung Cancer. vol. 88 (3).
Sjøblom, Bjørg; Grønberg, Bjørn Henning; Saltyte Benth, Jurate; Baracos, Vickie E.; Fløtten, Øystein; Hjermstad, Marianne Jensen; Aass, Nina Kathrine; Jordhøy, Marit. (2015) Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer. Lung Cancer. vol. 90 (1).
Stene, Guro Birgitte; Helbostad, Jorunn L.; Amundsen, Tore; Sørhaug, Sveinung; Hjelde, Harald Harris; Kaasa, Stein; Grønberg, Bjørn H.. (2015) Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer. Acta Oncologica. vol. 54 (3).